Role: Senior Director, US Brand Strategy & Launch, responsible for the end-to-end commercialization of Neurocrine’s upcoming Mood Disorders treatment in the US.
Responsibilities
- develop and execute a comprehensive brand strategy, including positioning, segmentation, messaging, and metrics
- lead cross-functional planning aligning marketing, medical, market access, sales, regulatory, and analytics teams
- shape engagement strategies for HCPs and patients based on neuropsychiatric landscape insights
- manage pre-launch and launch programs
- oversee budget and external agencies
- represent the brand in governance forums
- build external stakeholder relationships
- lead and develop a high-performing team
- operate in a highly matrixed environment
Requirements
- BS/BA in scientific or business discipline with 15+ years relevant experience, including 7+ years in pharma marketing or sales, with prior experience managing external agencies
- Master’s/MBA with 13+ years, or PhD with 10+ years and strong leadership background
- Proven success in U.S. brand strategy and launches in neuroscience, psychiatry, or specialty therapeutics
- Deep understanding of mental health HCP and patient dynamics
- Ability to influence senior leadership and lead cross-functional teams
- Excellent communication and stakeholder management skills
High-Value: CNS, Mood Disorders, US commercial launch, HCP and patient engagement, multi-channel marketing, 25-50% domestic travel.
#J-18808-Ljbffr